Frank Löscher Ph.D.
Chief Technology Officer
Dr. Frank Löscher joined the Novaliq management team in February 2014 and is responsible for the Business Development section of the company. This includes the outlicensing of Novaliq’s drug delivery technology as well as pharma and medical devices. Besides the outlicensing activities Dr. Löscher supervises the contract manufacturing of Novaliq’s products.
He graduated as Chemist at Ruprecht Karls University in Heidelberg and later received his Ph.D. in Biophysical Chemistry at the University of Regensburg.
Dr. Löscher has more than 15 years experience in various positions in R&D, project management, sales and business development with companies such as Molecular Machines & Industries, instrAction and Corden Pharma.